Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 272, Issue 4 35-4, 1997, Pages

  Kim, Michael S ^a   Chey, William D ^a   Owyang, Chung ^a   Hasler, William L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cholinergic nerves; electrophysiology; prostaglandins; vomiting

Indexed keywords

ATROPINE; INDOMETACIN; PROSTAGLANDIN; VASOPRESSIN;

ADULT; ARTICLE; CHOLINERGIC NERVE; CONTROLLED STUDY; ELECTROGASTROGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOTION SICKNESS; NAUSEA; NORMAL HUMAN; PRIORITY JOURNAL; STOMACH; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

EID: 0030915770     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1997.272.4.g853     Document Type: Article

References (27)

1. Cheung, B. S. K., R. L. Kohl, K. E. Money, and L. B. Kinter. Etiologic significance of arginine vasopressin in motion sickness. J. Clin. Pharmacol. 34: 664-670, 1994.
2. Cheung, B. S. K., K. E. Money, R. L. Kohl, and L. B. Kinter. Investigation of anti-motion sickness drugs in the squirrel monkey. J. Clin. Pharmacol. 32: 163-175, 1992.
3. Dahl, E., D. Offer-Ohlsen, P. E. Lillevold, and L. Sandvik. Transdermal scopolamine, oral meclizine, and placebo in motion sickness. Clin. Pharmacol. Ther. 36: 116-120, 1984.
4. Domino, E. F., and G. Corasen. Central and peripheral effects of muscarinic cholinergic blocking agents in man. Anesthesiology 28: 568-574, 1967.
5. Fox, R. A., L. C. Neil, N. G. Daunton, and J. Lucot. Vasopressin and motion sickness in cats. Aviat. Space Environ. Med. 58, Suppl. 9: A143-A147, 1987.
6. Glick, S. M., and A. Kagan. Radioimmunoassay of arginine vasopressin. In: Methods of Hormone Radioimmunoassays, edited by B. M. Jaffe and H. R. Behrmann. New York: Academic, 1979, p. 341-351.
7. Hasler, W. L., M. S. Kim, W. D. Chey, V. Stevenson, B. Stein, and C. Owyang. Central cholinergic and α-adrenergic mediation of gastric slow wave dysrhythmias evoked during motion sickness. Am. J. Physiol. 268 (Gastrointest. Liver Physiol. 31): G539-G547, 1995.
8. Hasler, W. L., H. C. Soudah, G. Dulai, and C. Owyang. Mediation of hyperglycemia-evoked gastric slow wave dysrhythmias by endogenous prostaglandins. Gastroenterology 108: 727-736, 1995.
9. Kim, C. H., A. R. Zinsmeister, and J.-R. Malagelada. Mechanisms of canine gastric dysrhythmia. Gastroenterology 92: 993-999, 1987.
10. Koch, K. L., J. Summy-Long, S. Bingaman, N. Sperry, and R. M. Stern. Vasopressin and oxytocin responses to illusory self-motion and nausea in man. J. Clin. Endocrinol. Metab. 71: 1269-1275, 1990.
11. Kohagen, K., W. Hasler, M. Kim, W. M. McDonnell, W. D. Chey, and C. Owyang. Transdermal nicotine evokes gastric dysrhythmias via a prostaglandin-dependent pathway with associated antral hypomotility: a model for decreased gastric motility with smoking (Abstract). Gastroenterology 106: A525, 1994.
12. Kohl, R. L. β-Endorphin and arginine vasopressin following stressful sensory stimuli in man. Aviat. Space Environ. Med. 63: 986-993, 1992.
13. Lucot, J. B., and G. H. Crampton. Xylazine emesis, yohimbine and motion sickness susceptibility in the cat. J. Pharmacol. Exp. Ther. 237: 450-455, 1986.
14. Mogard, M. H., V. Maxwell, T. Kovacs, G. VanDeventer, J. D. Elashoff, T. Yamada, G. L. Kauffman, and J. H. Walsh. Somatostatin inhibits gastric acid secretion after gastric mucosal prostaglandin synthesis inhibition by indomethacin in man. Gut 26: 1189-1191, 1985.
15. Money, K. E. Motion sickness. Physiol. Rev. 50: 1-39, 1970.
16. Muth, E. R., R. M. Stern, M. Jokerst, and K. L. Koch. Effects of dimenhydrinate (Dramamine) on gastric myoelectric activity and vection-induced motion sickness (Abstract). Gastroenterology 104: A1054, 1993.
17. Rane, A., O. Oelz, J. C. Frolich, H. W. Seyberth, B. J. Sweetman, J. T. Watson, G. R. Wilkinson, and J. A. Oates. Relation between plasma concentration of indomethacin and its effect on prostaglandin synthesis and platelet aggregation in man. Clin. Pharmacol. Ther. 23: 658-668, 1978.
18. Sanders, K. M., and J. H. Szurszewski. Does endogenous prostaglandin affect gastric motility? Am. J. Physiol. 241 (Gastrointest. Liver Physiol. 4): G191-G195, 1981.
19. Stern, R. M., S. Q. Hu, M. W. Vasey, and K. L. Koch. Adaptation to vection-induced symptoms of motion sickness. Aviat. Space Environ. Med. 60: 566-572, 1989.
20. Stern, R. M., K. L. Koch, W. R. Stewart, and I. M. Lindblad. Spectral analysis of tachygastria recorded during motion sickness. Gastroenterology 92: 92-97, 1987.
21. Thomford, N. R., and K. R. Sirinek. Intravenous vasopressin in patients with portal hypertension: advantages of continuous infusion. J. Surg. Res. 18: 113-117, 1975.
22. Thornton, W. E., B. J. Linder, T. P. Moore, and S. L. Pool. Gastrointestinal motility in space motion sickness. Aviat. Space Environ. Med. 58A: 16-21, 1987.
23. Uijtdehaage, S. H., R. M. Stern, and K. L. Koch. Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility. Aviat. Space Environ. Med. 64: 1-8, 1993.
24. Wood, C. D. Antimotion sickness and antiemetic drugs. Drugs 17: 471-479, 1979.
25. Wood, C. D., J. J. Stewart, M. J. Wood, J. E. Manno, B. R. Manno, and M. E. Mims. Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness. Aviat. Space Environ. Med. 61: 157-161, 1990.
26. Wood, M. J., C. D. Wood, J. E. Manno, and H. M. Redetzki. Nuclear medicine evaluation of motion sickness and medications on gastric emptying time. Aviat. Space Environ. Med. 58: 1112-1114, 1987.
27. Xu, L. H., K. L. Koch, J. Summy-Long, R. M. Stern, J. F. Seaton, T. S. Harrison, L. M. Demers, and S. Bingaman. Hypothalamic and gastric myoelectrical responses during circular vection-induced nausea in healthy Chinese subjects. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E578-E584, 1993.